Active Brain & Nervous System Genetics & Molecular Biology

The role of astrocyte subtypes in neurodegeneration

In plain English

AI plain-English summary

Astrocytes—star-shaped brain cells that keep neural tissue healthy—come in distinct subtypes, and each one reacts differently when the brain is inflamed or degenerating. This matters because most research treats astrocytes as a single, uniform cell type, missing the fact that different subtypes may drive or protect against diseases like Alzheimer’s in different ways. The researcher has already identified two specific subtypes: a “super-responder” that clusters around amyloid plaques, and a surface-covering subtype defined by a single gene, *Myoc*. Understanding what triggers each subtype’s transformation and what they do next could reveal why some brain regions are more vulnerable to neurodegeneration than others. If this work succeeds, it could identify entirely new therapeutic targets for Alzheimer’s and other chronic neurodegenerative conditions—not by targeting all astrocytes broadly, but by selectively blocking or boosting the activity of specific subtypes. That precision could reduce side effects and improve treatment outcomes. This is fundamental science. There is no immediate clinical application. But similar discoveries about cell-type diversity in the brain have already reshaped how researchers approach diseases like multiple sclerosis and Parkinson’s. A deeper map of astrocyte subtypes could do the same for neurodegeneration.

View original technical description
Astrocytes are a highly abundant cell type in the central nervous system. They perform critical homeostatic functions but respond to insults by undergoing a ‘reactive transformation’. By applying integrative single cell RNA-seq and genome-wide spatial transcriptomics I have recently discovered that astrocytes fall into discrete subtypes that occupy distinct spaces in the brain, and that each subtype undergoes a subtype-specific reactive transformation during brain inflammation. Key goals of my project are understanding how homeostatic, regionally-restricted astrocyte subtypes turn into specialized reactive subtypes in neuroinflammation and chronic neurodegeneration, particularly Alzheimer’s disease (AD). I have already identified two subtypes relevant to neurodegeneration: 1 – An astrocyte ‘super-responder’ subtype that is induced by type-I-interferons and is selectively present around amyloid plaque depositions. 2 – I identified the transcriptomic identity of glia limitans superficialis astrocytes that cover the entire brain and spinal cord surface and can be described by a single gene, Myoc. Using scRNA-seq, spatial transcriptomics, advanced bioinformatic analyses as well as novel and established astrocyte-specific transgenic mice combined with functional in vitro assays, I will uncover the upstream-inducers and downstream functions of specialized astrocyte subtypes in order to identify novel therapeutic targets in neurodegeneration and neuroinflammation.

View the original record at the funder ↗

Researchers

Philip Hasel (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Role of IFNGR1 in reactive astrocyte activation
Transgenic approaches to understanding astrocyte heterogeneity
Autophagy control of human neuroinflammatory signalling pathways
Coordinate regulation of a protective phenotype in astrocytes
Inducing neuroprotective responses in astrocytes using human stem cell models

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.